Skip to main content
EJNMMI Research
Fig. 1 | EJNMMI Research

Fig. 1

From: Pharmacodynamics and biodistribution of [195mPt]cisplatin(CISSPECT®) in head and neck squamous cell carcinoma

Fig. 1

Dose-response curves of VU-SCC-1131 (A) and VU-SCC-OE (B). Table C shows IC50 values for both the conventional¹ and the recovery² experiment in cisplatin-free medium. ¹ (Conventional) Numbers represent percentage of cell death after a conventional dose-response experiment with 72 h continues cisplatin exposure. ² (Recovery) Numbers represent percentage of cell death after a dose-response experiment with 4 h cisplatin exposure and 72 h recovery in cisplatin-free medium

Back to article page